Interstitial Lung Disease: An Overview



September 18 is Interstitial Lung Disease Day.

Interstitial lung disease (ILD) is a broad category of respiratory diseases, characterized by inflammation and scarring in the interstitium, the tissue surrounding the alveoli, the tiny air sacs where gas exchange occurs in the lungs. This scarring makes it difficult for oxygen to pass from the lungs into the bloodstream, leading to shortness of breath and fatigue. ILD encompasses over 200 distinct conditions, varying in cause, progression, and treatment, but all share the common feature of interstitial fibrosis.

Symptoms and Diagnosis


The primary symptoms of ILD are dyspnea (shortness of breath) and cough. As the disease advances, patients may experience fatigue, weight loss, and chest pain. In severe cases, blue discoloration of the skin and lips (cyanosis) can occur due to inadequate oxygenation of the blood. Diagnosis of ILD involves a combination of medical history, physical examination, lung function tests, imaging studies, and sometimes biopsy. High-resolution computed tomography (HRCT) scans are particularly useful in visualizing the interstitial scarring. Lung function tests, such as spirometry and diffusion capacity, quantify the degree of lung impairment.


Treatment and Outcomes


Treatment of ILD depends on the underlying cause. For idiopathic pulmonary fibrosis (IPF), the most common type of ILD, there is no cure, and treatment focuses on slowing disease progression and managing symptoms. Medications such as nintedanib and pirfenidone can slow the rate of forced vital capacity decline. Oxygen therapy is often necessary to combat hypoxia. Pulmonary rehabilitation programs, which include exercise training, education, and support, can improve quality of life. Lung transplantation may be considered for advanced cases. The prognosis for ILD varies widely depending on the specific type and rate of progression.


Known Causes of ILD


Patients with some inflammatory and connective tissue diseases are at a higher risk for ILD. These conditions include many AiArthritis diseases like rheumatoid arthritis, systemic scleroderma, myositis, including dermatomyositis and polymyositis (DM and PM), sarcoidosis, and Sjögren's.


By Kelly Conway


Large conference audience facing a projected presentation in a hotel ballroom conference hall.
April 22, 2026
Explore insights from the BMS Forum on autoimmune and autoinflammatory arthritis, highlighting patient experiences, research updates, and advances in care to improve understanding and treatment outcomes.
A person sits at a desk, leaning forward with one hand to their head and the other holding their lower back in pain.
April 4, 2026
Describing pain can improve patient provider communication. Discover tips on how to describe pain in AiArthritis diseases
A calculator and stethoscope rest on a background of an EKG graph, with a small red heart figure placed near the tubes.
April 4, 2026
Heart health doesn’t always get the attention it deserves in AiArthritis disease care. Learn why this needs to change.
A person in dark pajamas lies on the floor with a laptop, surrounded by crumpled tissues, looking distressed.
April 4, 2026
Learn about the latest information about brain fog and sleep issues in AiArthritis diseases
More Posts